1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 9
1.2 List of Figures 13
2 Introduction 14
2.1 Pain Management Overview 14
3 Products under Development 15
3.1 Pain Management - Pipeline Products by Stage of Development 15
3.2 Pain Management - Pipeline Products by Territory 16
3.3 Pain Management - Pipeline Products by Regulatory Path 17
3.4 Pain Management - Pipeline Products by Estimated Approval Date 18
3.5 Pain Management - Ongoing Clinical Trials 19
4 Pain Management - Pipeline Products under Development by Companies 20
4.1 Pain Management Companies - Pipeline Products by Stage of Development 20
4.2 Pain Management - Pipeline Products by Stage of Development 22
5 Pain Management Companies and Product Overview 24
5.1 Advanced Amputee Solutions, LLC Company Overview 24
5.2 Algodyne Ltd Company Overview 25
5.3 Algometron Pty Ltd Company Overview 26
5.4 Aptima, Inc. Company Overview 27
5.5 Avacen Inc. Company Overview 28
5.6 AxioMedic Inc Company Overview 29
5.7 BioElectronics Corp Company Overview 30
5.8 Blacktown NC LLC Company Overview 33
5.9 Cerimon Pharmaceuticals, Inc. (Inactive) Company Overview 34
5.10 CoolSense Medical Ltd. Company Overview 35
5.11 Diavibe, Inc. Company Overview 36
5.12 Easytech Srl Company Overview 37
5.13 EP Global Communications, Inc. Company Overview 38
5.14 GRoK Technologies LLC Company Overview 40
5.15 Hadassah Medical Center Company Overview 41
5.16 Headway Company Overview 42
5.17 IMEXCO General Ltd. Company Overview 44
5.18 Immuno-Genic Corporation Company Overview 45
5.19 Intralink-Spine LLC Company Overview 46
5.20 Intronix Technologies Corporation Company Overview 47
5.21 Kalaco Scientific, Inc. Company Overview 48
5.22 Lasmed, LLC Company Overview 49
5.23 Magzor Corporation Company Overview 50
5.24 Mathematical Bio-Solutions Inc. Company Overview 51
5.25 Medasense Biometrics Ltd Company Overview 52
5.26 Meddynamics Ltd. Company Overview 54
5.27 Medovex Corporation Company Overview 55
5.28 Myelyx Medical Company Overview 57
5.29 NeoMedLight Company Overview 58
5.30 NeuroMetrix Inc Company Overview 59
5.31 Neurospectrum LLC Company Overview 62
5.32 Omron Healthcare Co Ltd Company Overview 63
5.33 Orthovative Technologies Company Overview 64
5.34 Sea Run Holdings Inc Company Overview 65
5.35 Stanford University Company Overview 66
5.36 Tecnalia Corporacion Tecnologica Company Overview 68
5.37 Teijin Pharma Ltd Company Overview 69
5.38 Tyndall National Institute Company Overview 70
5.39 University of California San Diego Company Overview 71
5.40 University of Limerick Company Overview 72
5.41 University of Rochester Company Overview 73
5.42 University of Texas Medical Branch at Galveston Company Overview 74
5.43 University of Washington Company Overview 75
5.44 VascuActive Ltd Company Overview 76
5.45 Vertech Inc Company Overview 77
5.46 West Virginia University Company Overview 78
6 Pain Management- Recent Developments 79
6.1 Nov 29, 2016: NeuroMetrix Receives CE Mark Certification for Quell Wearable Pain Relief Device 79
6.2 Nov 23, 2016: Zynex to Raise USD1.5 Million in Private Placement 79
6.3 Nov 16, 2016: NeuroMetrix' Quell Device Makes Second Appearance at American Society of Regional Anesthesia's Annual Pain Medicine Meeting 79
6.4 Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 80
6.5 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 81
6.6 Nov 14, 2016: DJO Global Announces Appointment of Brady Shirley as President and Chief Executive Officer 81
6.7 Nov 14, 2016: Acura Pharmaceuticals Announces Third Quarter 2016 Financial Results 82
6.8 Nov 14, 2016: Dynatronics Announces 10% increase in Top Line Sales for Fiscal 2017 First Quarter 82
6.9 Nov 10, 2016: NeuroMetrix Chief Commercial Officer Frank McGillin to Present Quell Wearable Pain Relief Technology at 16th Annual Diabetes Technology Meeting 83
6.10 Nov 10, 2016: Zynex Announces Third Quarter 2016 Profit 84
6.11 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million 84
6.12 Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer 85
6.13 Nov 08, 2016: DJO Global Announces Financial Results for Third Quarter 86
6.14 Nov 07, 2016: Theralase Technologies Raises USD3.2 Million in Public Offering of Units 87
6.15 Nov 07, 2016: Aralez Reports Third Quarter 2016 Financial Results 87
6.16 Nov 07, 2016: Nevro Reports Third Quarter 2016 Financial Results 89
6.17 Nov 03, 2016: Medovex Conducts Successful Cadaver Lab at NASS 2016 90
6.18 Nov 03, 2016: Cara Therapeutics Reports Third Quarter 2016 Financial Results 91
6.19 Nov 02, 2016: Medovex Announces Successful Largest Living Tissue Population Test to Date 92
6.20 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 93
6.21 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results 93
6.22 Oct 27, 2016: NeuroMetrix Announces Issuance Of New U.S. Patent For Quell Wearable Pain Relief Technology 100
6.23 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 100
6.24 Oct 26, 2016: Bovie Medical Reports 2016 Third Quarter and Nine Month Results 101
6.25 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 103
6.26 Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 104
6.27 Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results 105
6.28 Oct 20, 2016: ICON Announces Executive Leadership Transition 106
6.29 Oct 20, 2016: ICON Reports Third Quarter 2016 Results 106
6.30 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 107
6.31 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 108
6.32 Oct 13, 2016: Medovex Reports Successful Demonstration of Expanding EMEA Business at EuroSpine 2016, Berlin, Germany 109
6.33 Oct 13, 2016: AVACEN Medical Announces Support for New ClinicalTrials.gov Initiative 109
6.34 Oct 11, 2016: U.S. Special Forces Begins Testing Of Oska Wellness Pulsed Electromagnetic Field Device For Use In Pain Management 110
6.35 Oct 11, 2016: Relievant MedSystems Raises USD36 Million in Equity Financing 111
6.36 Oct 10, 2016: NeuroMetrix Announces Participation in Discover Blue: New York City Bluetooth Event 111
6.37 Oct 10, 2016: BioElectronics Comments on its U.S. FDA's OTC Market Clearance Application 111
6.38 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 112
6.39 Oct 06, 2016: Zygood Raises USD0.2 Million in Venture Financing 112
6.40 Oct 05, 2016: NeuroMetrix to Sponsor Study Assessing the Impact of Quell Technology on Chronic Low Back Pain 112
6.41 Oct 05, 2016: HYPERICE Introduces VENOM, a Wearable Back Device That Harnesses the Power of Heat and Vibration for Maximum Warm Up and Recovery 113
6.42 Oct 04, 2016: Relaxis Pad for Restless Legs Syndrome Helps Patients Avoid General Anesthesia 113
6.43 Oct 03, 2016: BioElectronics ActiPatch Drug-free Pain Therapy to be Featured at Pharmacy Week in Trinidad & Tobago W.I. 114
6.44 Sep 30, 2016: Dynatronics Welcomes David A. Wirthlin as Its New Chief Financial Officer 115
6.45 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare 115
6.46 Sep 28, 2016: BioElectronics Submits Back Pain Relief & Medication Use Side Effects Registry Study for Publication 116
6.47 Sep 28, 2016: NanoVibronix Announces Distribution Agreement With Mano Equestrian Services (PTE) LTD in Singapore for Equine PainShield 116
6.48 Sep 26, 2016: Dynatronics Announces Fourth Quarter and Fiscal Year 2016 Financial Results 116
6.49 Sep 22, 2016: NeuroMetrix Announces Quell Fibromyalgia Pilot with Synovation Medical Group 117
6.50 Sep 20, 2016: Professional athletic trainers adopt sam Sport to accelerate injury recovery and reduce opioid use for pain management 118
6.51 Sep 20, 2016: NeuroMetrix Reports Progress on Quell Availability within the Veterans Health Administration 119
6.52 Sep 14, 2016: Medovex Enters Into International Distribution Agreement With M.Fast Technologies 119
6.53 Sep 13, 2016: BioElectronics Launches ActiPatch, Musculoskeletal Pain Therapy In Sweden 120
6.54 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 120
6.55 Sep 13, 2016: Zynex Announces August Orders 121
6.56 Sep 08, 2016: NeuroMetrix Announces Quell Dispensing Partnership with Comprehensive Pain Specialists 121
6.57 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation 121
6.58 Sep 06, 2016: DJO Global Announces Appointment of Mike Eklund as Chief Operating Officer and Chief Financial Officer 122
6.59 Sep 06, 2016: Sanofi Board Of Directors Provides Update 122
6.60 Sep 05, 2016: Teijin Publishes Integrated Report 2016 123
6.61 Aug 30, 2016: SANUWAVE Health Reports Record Year to Date Order Book for orthoPACE and dermaPACE – Up 280% Over 2015 123
6.62 Aug 29, 2016: TetraGenetics Enters into Partnership with Pharmaceutical Company 124
6.63 Aug 26, 2016: Relievant MedSystems Raises USD22.2 Million in Venture Financing 124
6.64 Aug 25, 2016: NeuroMetrix Announces That Quell Will Be Featured in the Target Open House 124
6.65 Aug 25, 2016: Medovex Adds 35 Year Orthopedic Industry Veteran Ron Lawson to Board of Directors 124
6.66 Aug 24, 2016: Medovex Begins Commercial Production of DenerveX Pro-40 Generator in Preparation for EU Launch 125
6.67 Aug 24, 2016: Acrux: Financial Report for the year ended 30 June 2016 126
6.68 Aug 23, 2016: Pyng Medical Reports Third Quarter Fiscal 2016 Results 127
6.69 Aug 22, 2016: Zynex Announces Second Quarter 2016 Results 127
6.70 Aug 16, 2016: NeuroMetrix Commentary on Strategic and Business Partnerships for Quell Wearable Pain Relief Technology 128
6.71 Aug 16, 2016: Zynex Announces July Orders 129
6.72 Aug 15, 2016: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update 129
6.73 Aug 09, 2016: Aralez Reports Second Quarter 2016 Financial Results 130
6.74 Aug 08, 2016: Acura Pharmaceuticals Announces Second Quarter 2016 Financial Results 132
6.75 Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results 132
6.76 Aug 05, 2016: Medovex Raises USD1.2 Million in Private Placement of Units 133
6.77 Aug 04, 2016: Syneron Medical Reports Second Quarter 2016 Revenue of $75.0 Million and Non-GAAP EPS of $0.09 133
6.78 Aug 04, 2016: Cara Therapeutics Reports Second Quarter 2016 Financial Results 135
6.79 Aug 03, 2016: NeuroMetrix To Present Quell Wearable Pain Technology at National Association of Chain Drug Stores Total Store Expo 136
6.80 Aug 02, 2016: NeuroMetrix Reports that the Quell Health Cloud Has Collected Over 1 Million Hours of Quell Therapy and Health Data 136
6.81 Aug 01, 2016: Bovie Medical Reports Second Quarter and First Half 2016 Results 137
7 Appendix 218
7.1 Methodology 218
7.2 About GlobalData 220
7.3 Contact Us 220
7.4 Disclaimer 221

1.1 List of Tables
Table 1: Pain Management - Pipeline Products by Stage of Development 16
Table 2: Pain Management - Pipeline Products by Territory 17
Table 3: Pain Management - Pipeline Products by Regulatory Path 18
Table 4: Pain Management - Pipeline Products by Estimated Approval Date 19
Table 5: Pain Management - Ongoing Clinical Trials 20
Table 6: Pain Management Companies - Pipeline Products by Stage of Development 21
Table 7: Pain Management - Pipeline Products by Stage of Development 23
Table 8: Advanced Amputee Solutions, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 9: I.E.P. - Product Status 25
Table 10: I.E.P. - Product Description 25
Table 11: Algodyne Ltd Pipeline Products & Ongoing Clinical Trials Overview 26
Table 12: PainGauge - Product Status 26
Table 13: PainGauge - Product Description 26
Table 14: Algometron Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 27
Table 15: Algotect Device - Product Status 27
Table 16: Algotect Device - Product Description 27
Table 17: Aptima, Inc. Pipeline Products & Ongoing Clinical Trials Overview 28
Table 18: System For Tracking And Managing Pain - Product Status 28
Table 19: System For Tracking And Managing Pain - Product Description 28
Table 20: Avacen Inc. Pipeline Products & Ongoing Clinical Trials Overview 29
Table 21: AVACEN 100 - Fibromyalgia - Product Status 29
Table 22: AVACEN 100 - Fibromyalgia - Product Description 29
Table 23: AxioMedic Inc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 24: Canker Cover Kid - Product Status 30
Table 25: Canker Cover Kid - Product Description 30
Table 26: BioElectronics Corp Pipeline Products & Ongoing Clinical Trials Overview 31
Table 27: Actipatch - Product Status 31
Table 28: Actipatch - Product Description 32
Table 29: BioElectronics Corp - Ongoing Clinical Trials Overview 32
Table 30: Actipatch - A Randomized Controlled Trial to Assess the Benefits of ActiPatch-pulsed Shortwave Therapy for Chronic Lower Back Pain 33
Table 31: Actipatch - Evaluation of Postoperative Edema and Pain Following Third Molar Extraction with Application of Pulsed Electromagnetic Field (PEMF) Therapy 33
Table 32: Blacktown NC LLC Pipeline Products & Ongoing Clinical Trials Overview 34
Table 33: AFXT - Product Status 34
Table 34: AFXT - Product Description 34
Table 35: Cerimon Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 35
Table 36: Topical Diclofenac Patch - Product Status 35
Table 37: Topical Diclofenac Patch - Product Description 35
Table 38: CoolSense Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 36
Table 39: MigraSense - Product Status 36
Table 40: MigraSense - Product Description 36
Table 41: Diavibe, Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 42: Diavibe Device - Pain - Product Status 37
Table 43: Diavibe Device - Pain - Product Description 37
Table 44: Easytech Srl Pipeline Products & Ongoing Clinical Trials Overview 38
Table 45: Portable Hyperthermia System - Product Status 38
Table 46: Portable Hyperthermia System - Product Description 38
Table 47: EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 48: MPTT Device - Product Status 39
Table 49: MPTT Device - Product Description 39
Table 50: Muscle Pain Detection Device - Diagnostic Use - Product Status 40
Table 51: Muscle Pain Detection Device - Diagnostic Use - Product Description 40
Table 52: GRoK Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 41
Table 53: Scionic - Product Status 41
Table 54: Scionic - Product Description 41
Table 55: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 42
Table 56: Virtual Pain Killer - Product Status 42
Table 57: Virtual Pain Killer - Product Description 42
Table 58: Headway Pipeline Products & Ongoing Clinical Trials Overview 43
Table 59: Occiflex Device - Product Status 43
Table 60: Occiflex Device - Product Description 43
Table 61: OcciHome - Product Status 44
Table 62: OcciHome - Product Description 44
Table 63: IMEXCO General Ltd. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 64: Neuro - CPD - Product Status 45
Table 65: Neuro - CPD - Product Description 45
Table 66: Immuno-Genic Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
Table 67: Ig2000 System - Product Status 46
Table 68: Ig2000 System - Product Description 46
Table 69: Intralink-Spine LLC Pipeline Products & Ongoing Clinical Trials Overview 47
Table 70: NEXT Device - Product Status 47
Table 71: NEXT Device - Product Description 47
Table 72: Intronix Technologies Corporation Pipeline Products & Ongoing Clinical Trials Overview 48
Table 73: Myoguide Multi - Product Status 48
Table 74: Myoguide Multi - Product Description 48
Table 75: Kalaco Scientific, Inc. Pipeline Products & Ongoing Clinical Trials Overview 49
Table 76: Nexalin Device - Neuropathic Pain - Product Status 49
Table 77: Nexalin Device - Neuropathic Pain - Product Description 49
Table 78: Lasmed, LLC Pipeline Products & Ongoing Clinical Trials Overview 50
Table 79: Diode Laser Selective Stimulator - Product Status 50
Table 80: Diode Laser Selective Stimulator - Product Description 50
Table 81: Magzor Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
Table 82: AdaFlow - Product Status 51
Table 83: AdaFlow - Product Description 51
Table 84: Mathematical Bio-Solutions Inc. Pipeline Products & Ongoing Clinical Trials Overview 52
Table 85: Non-Invasive Pain Eliminator - Product Status 52
Table 86: Non-Invasive Pain Eliminator - Product Description 52
Table 87: Medasense Biometrics Ltd Pipeline Products & Ongoing Clinical Trials Overview 53
Table 88: PMD-200 - Product Status 53
Table 89: PMD-200 - Product Description 53
Table 90: Medasense Biometrics Ltd - Ongoing Clinical Trials Overview 54
Table 91: PMD-200 - Evaluation of the Last Version of the PMD200 and its NoL Index in Patients Undergoing Laparotomies with Intraoperative Epidural Analgesia 54
Table 92: Meddynamics Ltd. Pipeline Products & Ongoing Clinical Trials Overview 55
Table 93: Qi-100 - Product Status 55
Table 94: Qi-100 - Product Description 55
Table 95: Medovex Corporation Pipeline Products & Ongoing Clinical Trials Overview 56
Table 96: DenerveX Pro-40 Power Generator - Product Status 56
Table 97: DenerveX Pro-40 Power Generator - Product Description 56
Table 98: DenerveX System - Product Status 57
Table 99: DenerveX System - Product Description 57
Table 100: Myelyx Medical Pipeline Products & Ongoing Clinical Trials Overview 58
Table 101: Low-Back Pain Therapy Device - Product Status 58
Table 102: Low-Back Pain Therapy Device - Product Description 58
Table 103: NeoMedLight Pipeline Products & Ongoing Clinical Trials Overview 59
Table 104: Phototherapy Device - Pain Management - Product Status 59
Table 105: Phototherapy Device - Pain Management - Product Description 59
Table 106: NeuroMetrix Inc Pipeline Products & Ongoing Clinical Trials Overview 60
Table 107: Quell Platform - Smartphone Control - Product Status 60
Table 108: Quell Platform - Smartphone Control - Product Description 61
Table 109: Quell Wearable Pain Relief Device - Product Status 61
Table 110: Quell Wearable Pain Relief Device - Product Description 61
Table 111: NeuroMetrix Inc - Ongoing Clinical Trials Overview 62
Table 112: Quell Wearable Pain Relief Device - Efficacy of the Quell Wearable Device for Chronic Low Back Pain 62
Table 113: Quell Wearable Pain Relief Device - Quell Opioid Reduction and Pain Relief in Patients with Cancer 62
Table 114: Neurospectrum LLC Pipeline Products & Ongoing Clinical Trials Overview 63
Table 115: Monolith Posture Coach - Product Status 63
Table 116: Monolith Posture Coach - Product Description 63
Table 117: Omron Healthcare Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 64
Table 118: Omran Massage Pillow - Product Status 64
Table 119: Omran Massage Pillow - Product Description 64
Table 120: Orthovative Technologies Pipeline Products & Ongoing Clinical Trials Overview 65
Table 121: OrthoCorrect Patch - Product Status 65
Table 122: OrthoCorrect Patch - Product Description 65
Table 123: Sea Run Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 124: SEA-STAT TH - Product Status 66
Table 125: SEA-STAT TH - Product Description 66
Table 126: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 67
Table 127: Electroceutical Wireless System - Product Status 67
Table 128: Electroceutical Wireless System - Product Description 67
Table 129: Innovative Stimulus System - Product Status 68
Table 130: Innovative Stimulus System - Product Description 68
Table 131: Tecnalia Corporacion Tecnologica Pipeline Products & Ongoing Clinical Trials Overview 69
Table 132: Lumbia - Product Status 69
Table 133: Lumbia - Product Description 69
Table 134: Teijin Pharma Ltd Pipeline Products & Ongoing Clinical Trials Overview 70
Table 135: Pain Relief Device - Product Status 70
Table 136: Pain Relief Device - Product Description 70
Table 137: Tyndall National Institute Pipeline Products & Ongoing Clinical Trials Overview 71
Table 138: Smart Needle - Product Status 71
Table 139: Smart Needle - Product Description 71
Table 140: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 72
Table 141: Portable Device For Pain Relief - Product Status 72
Table 142: Portable Device For Pain Relief - Product Description 72
Table 143: University of Limerick Pipeline Products & Ongoing Clinical Trials Overview 73
Table 144: Exoskeleton - Product Status 73
Table 145: Exoskeleton - Product Description 73
Table 146: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 74
Table 147: Pain Monitoring System - Product Status 74
Table 148: Pain Monitoring System - Product Description 74
Table 149: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 75
Table 150: Virtual Reality Entertainment System - Product Status 75
Table 151: Virtual Reality Entertainment System - Product Description 75
Table 152: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 76
Table 153: Transcutaneous Acoustic Palpitation Device - Product Status 76
Table 154: Transcutaneous Acoustic Palpitation Device - Product Description 76
Table 155: VascuActive Ltd Pipeline Products & Ongoing Clinical Trials Overview 77
Table 156: VascuActive Device - Diabetic Peripheral Neuropathy - Product Status 77
Table 157: VascuActive Device - Diabetic Peripheral Neuropathy - Product Description 77
Table 158: Vertech Inc Pipeline Products & Ongoing Clinical Trials Overview 78
Table 159: Epidural Radiofrequency Catheter - Product Status 78
Table 160: Epidural Radiofrequency Catheter - Product Description 78
Table 161: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 79
Table 162: Pain Free Socket - Product Status 79
Table 163: Pain Free Socket - Product Description 79
Table 164: Glossary 220

1.2 List of Figures
Figure 1: Pain Management - Pipeline Products by Stage of Development 16
Figure 2: Pain Management - Pipeline Products by Territory 17
Figure 3: Pain Management - Pipeline Products by Regulatory Path 18
Figure 4: Pain Management - Pipeline Products by Estimated Approval Date 19
Figure 5: Pain Management - Ongoing Clinical Trials 20